As shown in Figure 5F, mice treated with AAV–IL-27 + control mAb showed reduced tumor growth compared with mice treated with AAV-ctrl virus + control mAb or AAV-ctrl virus + anti–PD-1. This evidence concerns the gene IL27 and neoplasm.